Allscripts reports 4B API exchanges since 2013

Allscripts has reached a new milestone, reporting more than 4 billion data shares through its application programming interfaces since the company began counting these exchanges in 2013.

Advertisement

Allscripts’ partners and clients use the company’s APIs for app deployment and data integration projects. Allscripts has certified more than 175 applications and devices from 8,000-plus developers through its Allscripts Developer Program, which enables third-party app developers to build solutions for the company’s app store using the APIs.

“We have made our API platform easily accessible and cost effective for developers to use, so that they can develop and test their solutions,” Tina Joros, vice president and general manager of the open business unit at Allscripts, said in a news release. “We are trying to create a new mentality of innovation for our clients, so that they view innovation as a path to improve overall workflows and connect with patients.”

More articles on EHRs & interoperability:
Meditech’s Q2 revenue up 7% from last year: 5 things to know
Most hospitals won’t reach HIMSS Analytics Stage 7 until 2035, study finds
16 hospitals, health systems seeking Allscripts, Cerner, Epic, Meditech talent

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in EHRs / Interoperability

Advertisement

Comments are closed.